THE LIND PARTNERS, LLC
THE LIND PARTNERS, LLC is a Series C+ and other fund in the US, Australia, Canada and United Kingdom investing in Healthcare, biotechnology, pharmaceuticals, mining and technology.
- Stages
- Series C+, other
- Sectors
- Healthcare, biotechnology, pharmaceuticals, mining, technology
- Invests in
- US-wide, Australia, Canada, United Kingdom
- Actively investing
- Yes
- Founded
- 2009
- Assets under management
- $165.4M
Check size not disclosed
Thesis
The Lind Partners, LLC is an alternative asset management firm founded in 2009 and headquartered in New York City. They specialize in providing growth capital to small and mid-cap publicly traded companies, particularly those with market capitalizations under $500 million. Their investment strategy primarily involves post-IPO debt and equity investments, targeting sectors such as biotechnology, healthcare, pharmaceuticals, mining, and technology. Geographically, they focus on Australia, Canada, the United Kingdom, and the United States. The firm manages various institutional funds and proprietary capital, acting as an investment manager and advisor. As of December 31, 2025, their AUM was reported at $153,067,022. The firm has a track record of 26 IPOs and 4 acquisitions within its portfolio.
Common questions
Does THE LIND PARTNERS, LLC invest at the Series C+ stage?
Yes. THE LIND PARTNERS, LLC lists Series C+ and other among the stages it invests in.
Where does THE LIND PARTNERS, LLC invest?
THE LIND PARTNERS, LLC invests in the US, Australia, Canada and United Kingdom.